Skip to main content
logo
Opus Genetics, Inc. (IRD)
NASDAQ: IRD · Real-Time Price · USD
3.470
-0.350 (-9.16%)
At close: Oct 23, 2026, 4:00 PM EDT
3.610
+0.140 (4.03%)
Pre-market: Oct 26, 2026, 5:39 AM EDT

Opus Genetics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
9.8614.210.9919.0539.850.59
Revenue Growth
-36.09%29.15%-42.30%-52.20%6665.70%-
Gross Profit
-28.77-16.62-15.861.425.5-14.58
Operating Income
-50.61-38.6-34.07-10.5618.23-22.71
Net Income
-107.61-49.59-57.53-9.9917.89-56.69
Earnings Per Share
-1.29-0.80-2.15-0.460.87-3.82
EPS Growth
------

Cash & Debt
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
88.8145.0930.3250.5242.6824.75
Total Debt
36.21.13---0.54
Net Cash (Debt)
52.6143.9630.3250.5242.6824.22
Net Cash Growth
67.39%44.98%-39.97%18.35%76.27%47.66%
Net Cash Per Share
0.630.711.142.342.071.63

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-40.67-35.25-25.58-1.1114.31-19.37
Capital Expenditures
------0.1
Free Cash Flow
-40.67-35.25-25.58-1.1114.31-19.47
Free Cash Flow Growth
------

Margins
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-291.85%-117.05%-144.28%7.33%63.98%-
Operating Margin
-513.47%-271.90%-309.99%-55.45%45.74%-3854.84%
Pretax Margin
-1091.82%-349.33%-523.40%-52.36%45.68%-9625.30%
Profit Margin
-1091.82%-349.33%-523.40%-52.42%44.89%-9625.30%
FCF Margin
-412.61%-248.33%-232.68%-5.84%35.92%-3305.60%

Valuation
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
----4.11-
Forward PE
-6.026.026.0214.08-
P/FCF Ratio
----5.13-
PS Ratio
29.299.773.423.581.84109.56